News und Analysen
Sirona Biochems klinische Studie zu TFC-1067 zur Veröffentlichung im Journal of Cosmetic Dermatology angenommen
Vancouver, Kanada – 26. Oktober 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (US-OTC: SRBCF) („Sirona“) freut sich bekannt zu geben, dass die von Dr. Zoe Draelos von der Firma
Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic Dermatology
Vancouver, Canada – October 26, 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that the clinical study using .2% TFC-1067 and conducted
Aurinia Presents Voclosporin Efficacy and Pharmacokinetic Data from Integrated Analysis of AURA-LV and AURORA Pivotal Trials at ASN Kidney Week 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications
EnWave kündigt Aktienrückkaufprogramm an
Vancouver, B.C., 19. Oktober 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave" oder das "Unternehmen" - https://www.commodity-tv.com/play/enwave-update-on-covid-19-impact-rev-machine
EnWave Announces Normal Course Issuer Bid
Vancouver, B.C., October 19, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave,” or the "Company” - https://www.commodity-tv.com/play/enwave-update-on-covid-19-impact-rev-machine-sales
IMV Inc. Re-establishes At-the-Market Facility
IMV Inc. (TSX: IMV; NASDAQ: IMV) (the "Company" or “IMV”), a clinical-stage biopharmaceutical company, today announced that it has entered into an equity distribution agreement, dated October 16
NeutriSci Enters the Second Highest Grossing Market with New Distribution in the State of Washington
Vancouver, British Columbia – October 15, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company
NeutriSci betritt mit dem US-Bundesstaat Washington den Markt mit den zweithöchsten Cannabis-Umsätzen weltweit
Vancouver (British Columbia), 15. Oktober 2020 - NeutriSci International Inc. (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) („NeutriSci“ oder das „Unternehmen“, ein innovatives
Biomarkers Associated With Clinical Response in Patients With r/r DLBCL Treated With DPX-Survivac Combination Therapy to be Presented at the Upcoming SITC Annual Meeting
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announces that
EnWave Signs Technology Evaluation and License Option Agreement with American Industrial Hemp Producer
Vancouver, B.C., October 14, 2020 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) announced today
EnWave unterzeichnet Technologiebewertungsabkommen inklusive Lizenzoptionen mit amerikanischem Industriehanfproduzenten
Vancouver, B.C., 14. Oktober 2020 - Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/) gab
Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced Time Is Nephrons, the first-ever lupus nephritis (LN) disease-state awareness campaign for
Sirona Biochem unterzeichnet Vertrag mit weltweit agierendem Pharmaunternehmen für klinische Studie zu seinem neuartigen Hautpflegewirkstoff TFC-1067
Vancouver, Kanada - 13. Oktober 2020 - Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (US-OTC: SRBCF) („Sirona“) freut sich bekannt zu geben, dass man mit einem der 10 führenden weltweit
Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skin Care Compound TFC-1067
Vancouver, Canada - October 13, 2020 - Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that it has signed an agreement with a top 10 global
Neutrisci Partner Tabletz LLC Launches Website and Social Media Platforms to Conquer Japanese CBD Market
VANCOUVER, BC / October 8, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT:1N9), an innovative technology company developing products for
NeutriSci Partner Tabletz LLC launcht Website und Social-Media-Plattformen zur Eroberung des japanischen CBD-Marktes
VANCOUVER, BC / 8. Oktober 2020 / NeutriSci International Inc. („NeutriSci“ oder das „Unternehmen“) (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9) - ein innovatives Technologieunternehmen, welches
IMV Provides Updates On COVID-19 Vaccine Program
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today provides updates on
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today
Relay Medical and Fio Corporation Announces High-Volume Manufacturing Partner for its COVID-19 Mobile Testing Device, Fionet, to Support Scaled-Up Production
- Relay & Fio announces engagement with contact manufacturer KeyTronic for high-volume production of its COVID-19 mobile testing device, which enables rapid COVID-19 testing &
Relay Medical und Fio Corporation beauftragen Produktionspartner mit hohen Kapazitäten mit der Herstellung ihres mobilen COVID-19-Testgeräts Fionet, um sich für eine Produktionssteigerung zu rüsten
- Relay & Fio geben bekannt, dass sie den Auftragshersteller KeyTronic unter Vertrag genommen haben. Diese Firma ist in der Lage, das mobile COVID-19-Testgerät in einer hohen
EnWave unterzeichnet Geräte-Kaufvertrag mit Intakt Snacks aus Chile
Vancouver, B.C., 29. September 2020, EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" -
EnWave Signs Equipment Purchase Agreement with Intakt Snacks of Chile
Vancouver, B.C., September 29, 2020, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/play/enwave-update-on-covid-19-impact-rev-machine-sale
NeutriSci Provides Corporate Update
NeutriSci's Japan partner doing big "soft-launch" event on October 8/9
VANCOUVER, BC / September 28, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXC
NeutriSci stellt Unternehmensupdate bereit
Japanischer Partner von NeutriSci richtet am 8./9. Oktober große „Soft Launch“-VIP-Veranstaltungen aus
VANCOUVER, BC / 28. September 2020 / NeutriSci International Inc. („NeutriSci“ oder
Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (Aurinia or the Company), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple autoimmune